Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer-Reference-Cited by-同舟云学术

Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

Published:2013-02-10 Issue:3 Volume:19 Page:329-336
ISSN:1078-8956
Container-title:Nature Medicine
language:en
Short-container-title:Nat Med

Author:

Heo Jeong,Reid Tony,Ruo Leyo,Breitbach Caroline J,Rose Steven,Bloomston Mark,Cho Mong,Lim Ho Yeong,Chung Hyun Cheol,Kim Chang Won,Burke James,Lencioni Riccardo,Hickman Theresa,Moon Anne,Lee Yeon Sook,Kim Mi Kyeong,Daneshmand Manijeh,Dubois Kara,Longpre Lara,Ngo Minhtran,Rooney Cliona,Bell John C,Rhee Byung-Geon,Patt Richard,Hwang Tae-Ho,Kirn David H

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://www.nature.com/articles/nm.3089.pdf

Reference26 articles.

1. Kaufman, H.L. et al. Local and distant immunity induced by intralesional vaccination with an oncolytic herpes virus encoding GM-CSF in patients with stage IIIc and IV melanoma. Ann. Surg. Oncol. 17, 718–730 (2010).

2. Kirn, D., Martuza, R.L. & Zwiebel, J. Replication-selective virotherapy for cancer: biological principles, risk management and future directions. Nat. Med. 7, 781–787 (2001).

3. Liu, T.C., Galanis, E. & Kirn, D. Clinical trial results with oncolytic virotherapy: a century of promise, a decade of progress. Nat. Clin. Pract. Oncol. 4, 101–117 (2007).

4. Chiocca, E.A. Oncolytic viruses. Nat. Rev. Cancer 2, 938–950 (2002).

5. Heise, C. & Kirn, D.H. Replication-selective adenoviruses as oncolytic agents. J. Clin. Invest. 105, 847–851 (2000).

Cited by 635 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mpox Virus and its ocular surface manifestations;The Ocular Surface;2024-10

2. Dose Considerations for Vaccinia Oncolytic Virus Based on Retrospective Reanalysis of Early and Late Clinical Trials;Vaccines;2024-09-03

3. Advancements in second-line treatment research for hepatocellular carcinoma;Clinical and Translational Oncology;2024-08-20

4. Immunosuppressive tumor microenvironment in the progression, metastasis, and therapy of hepatocellular carcinoma: from bench to bedside;Experimental Hematology & Oncology;2024-08-01

5. A phase I clinical trial of intrahepatic artery delivery of TG6002 in combination with oral 5-fluorocytosine in patients with liver-dominant metastatic colorectal cancer;2024-07-31